Literature DB >> 35780018

Nutritional management of severe acute pancreatitis.

Li-Peng Huang1, Shui-Fang Jin2, Rong-Lin Jiang3.   

Abstract

Entities:  

Year:  2022        PMID: 35780018      PMCID: PMC9233745          DOI: 10.1016/j.hbpd.2022.06.015

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


× No keyword cloud information.
Severe acute pancreatitis (SAP) is a common clinical emergency and critical illness. The increases of hyperlipidemic pancreatitis and alcoholic pancreatitis result in the increase of SAP. The SAP mortality is as high as 30% [1]. During the resuscitation and treatment of SAP, the metabolism changes require nutritional support. The individual metabolic status need personalized nutrition approach. SAP patients are in a state of extreme stress due to inflammation, hemodynamic instability and severe hypoxia [2]. Due to acute respiratory distress syndrome, distributive shock or hypovolemic shock, the cell mitochondria are severely hypoxic. Instead of generating adequate ATP with the tricarboxylic acid cycle, only very limited ATP is produced in the mitochondria through intracytoplasmic glycolysis which also produces a large amount of organic acids such as lactic acid. In addition, patients with SAP encounter impaired insulin secretion, insulin resistance, over productions of glucocorticoids, catecholamines and glucagon, all of which cause hyperglycemia [3]. These patients need to apply insulin to maintain a proper blood glucose level and avoid the drastic fluctuation of blood glucose. Patients with SAP experience autophagy [4], a phenomenon in which the body catabolizes and metabolizes its own tissue components for the synthesis of inflammatory mediators and cytokines in stress situations, such as IL-1, IL-6, TNF-α, and fibrinogen. At this point, even if nutrients are given, they cannot be utilized. In addition, continuous renal replacement therapy (CRRT) is often applied in SAP patients to maintain the stability of the internal environment, regulate fluid balance, and remove inflammatory mediators. However, whether it is continuous veno-venous hemofiltration, hemodialysis or plasma exchange in CRRT, nutrients including glucose, amino acids, trace elements, vitamins and electrolytes, will lose from the body [5]. Special attention needs to be paid to CRRT patients to replenish various essential nutrients and maintain the stability of the internal environment. Once the hemodynamic and internal environments of SAP patients are stabilized, it is necessary to consider the nutritional therapy to meet the metabolic needs of the body and to avoid nutrient deficiencies such as hypoproteinemia, hypophosphatemia, and vitamin B1 deficiency [3]. The nutrients required by the body at this time are mainly glucose, amino acids, various electrolytes and vitamins. Since there are often co-morbidities as hyperlipidemia and liver damage, lipid emulsions should be applied with caution. The total calories (non-protein calories) should be measured by indirect calorimetry or given 25 kcal/kg initially [6], with a larger amount of glucose input to meet the body's energy metabolic requirements, and the insulin dose should be adjusted according to the blood glucose level. The ideal blood glucose level is 7-10 mmol/L. The protein supplement is 1.2-2.0 g/kg per day [7]. CRRT requires more protein supplement (2.5 g/kg per day) [8] and more vitamins and trace elements [9]. The electrolyte supplementation should be adjusted according to the blood electrolyte test results, paying particular attention to blood phosphorus and magnesium to avoid the refeeding syndrome due to the low blood phosphorus [10]. Enteral nutrition is a critical nutritional pathway for the body as it can replenish the nutrients required by the body's nutritional metabolism, and, satisfy the metabolic needs of intestinal microorganisms and maintain the intestinal mechanical, biological, immune and chemical barriers [11,12]. In very critical states such as serious impairment of the body's oxygen metabolism, extreme hemodynamic instability, and severe intestinal ischemia and hypoxia, the nutrition implementation should be hold for SAP patients. However, after the initial improvement of these conditions, the implementation of enteral nutrition should be considered. A small dose of enteral nutrition solution is usually titrated at the early stage of 24-48 h in the disease course [13,14]. And when possible, it is given through the nasogastric tube, with the application of metoclopramide and erythromycin if necessary to facilitate gastric emptying and prevent gastric retention and aspiration. If enteral nutrition is tolerated, the amount of enteral nutrition should be gradually increased to eventually reach 70% of the target caloric and protein amounts [15]. When enteral nutrition is being implemented, parenteral nutrition should be used as a supplement to enteral nutrition and conducted with appropriate quantity of various nutrients in the light of the enteral nutrition and the metabolic status. Particular attention should be paid to whether the enteral nutrition can reach 70% of the target calories and protein when SAP has continued for one week. If not, then parenteral nutrition should be supplemented [16]. For SAP patients, the metabolism of the body is seriously disrupted, and various therapeutic factors would interfere with the metabolism and distribution of nutrients. There are wide variety of nutrient requirements and metabolism among individuals in different pathophysiological states, and the gastrointestinal dysfunction affects the digestion and absorption of nutrients. Therefore, in early nutritional support for SAP patients, there should be close monitoring of their nutrition status [2], especially on proteins (amino acids), vitamins, trace elements. It is necessary to avoid both metabolic disorders caused by various nutrient deficiencies, such as phosphorus and thiamine deficiencies leading to refeeding syndrome [17], and nutritional overloads that exacerbate disturbances in the internal environment, such as protein overloads that lead to azotemia. Accordingly, the optimal therapeutic regimen should include early nutrition support while closely monitoring the levels of various nutrients to “make up for the deficiencies and get rid of the excesses” so that the patient can reach an optimal metabolic state for an early recovery. Potential enteral nutrition intolerance includes, inter alia, reflux aspiration, gastric retention, bloating, diarrhea, gastrointestinal bleeding and constipation, and should be monitored during the implementation of enteral nutrition. Patients with SAP are more prone to these intolerances due to serious abnormalities in their pathophysiological status. In this regard, a gradual approach should be adopted in the treatment, striving to start enteral nutrition early but not rushing to reach the full amount, and the nutritional deficiencies can be supplemented with parenteral nutrition to reach the goal, i.e. the so-called “complementary parenteral nutrition” [18]. In order to prevent and reduce the enteral nutrition intolerance, a clinical practice of elevating the head of bed ≥ 30° and post-pyloric feeding can be used to reduce regurgitation and aspiration. Digestive enzymes help digestion, metoclopramide or erythromycin are helpful for gastric emptying, and neostigmine promotes intestinal peristalsis. Traditional Chinese medical approaches such as dialectical treatment with Chinese herbs (gastric lavage or enema), acupuncture, and mirabilite applied to the umbilicus also have therapeutic effects. In conclusion, patients with SAP encounter a challenging metabolic state including catabolic and anaerobic processes that requires careful nutritional optimization. After the patient is stabilized, early enteral nutrition and supplemental parenteral nutrition should be initiated and dynamically adjusted according to the specific metabolic demands and gastrointestinal function which is also be influenced by the gut microecology. As the digestive and absorptive capacities improve, the level of nutrition should be increased without further exacerbating the metabolic demands during this state of critical illness.

Acknowledgments

None.

CRediT authorship contribution statement

Li-Peng Huang: Data curation, Investigation, Writing – original draft. Shui-Fang Jin: Data curation, Investigation, Writing – original draft. Rong-Lin Jiang: Conceptualization, Supervision, Writing – review & editing.
  18 in total

Review 1.  Management of Severe Acute Pancreatitis: An Update.

Authors:  Nina Gliem; Christoph Ammer-Herrmenau; Volker Ellenrieder; Albrecht Neesse
Journal:  Digestion       Date:  2020-05-18       Impact factor: 3.216

Review 2.  Enteral versus parenteral nutrition in critically ill patients with severe pancreatitis: a meta-analysis.

Authors:  H Yao; C He; L Deng; G Liao
Journal:  Eur J Clin Nutr       Date:  2017-09-13       Impact factor: 4.016

Review 3.  Practical guide to the management of acute pancreatitis.

Authors:  George Goodchild; Manil Chouhan; Gavin J Johnson
Journal:  Frontline Gastroenterol       Date:  2019-03-02

Review 4.  Nutrition management in acute pancreatitis: Clinical practice consideration.

Authors:  Narisorn Lakananurak; Leah Gramlich
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

Review 5.  Autophagy in the cellular energetic balance.

Authors:  Rajat Singh; Ana Maria Cuervo
Journal:  Cell Metab       Date:  2011-05-04       Impact factor: 27.287

6.  Refeeding Syndrome as a Possible Cause of Very Early Mortality in Acute Pancreatitis.

Authors:  Tae Joo Jeon; Kyong Joo Lee; Hyun Sun Woo; Eui Joo Kim; Yeon Suk Kim; Ji Young Park; Jae Hee Cho
Journal:  Gut Liver       Date:  2019-09-15       Impact factor: 4.519

Review 7.  Nutritional Support in Patients with Severe Acute Pancreatitis-Current Standards.

Authors:  Beata Jabłońska; Sławomir Mrowiec
Journal:  Nutrients       Date:  2021-04-28       Impact factor: 5.717

8.  Enteral nutrition within 48 hours of admission improves clinical outcomes of acute pancreatitis by reducing complications: a meta-analysis.

Authors:  Jie-Yao Li; Tao Yu; Guang-Cheng Chen; Yu-Hong Yuan; Wa Zhong; Li-Na Zhao; Qi-Kui Chen
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

9.  Efficacy comparisons of enteral nutrition and parenteral nutrition in patients with severe acute pancreatitis: a meta-analysis from randomized controlled trials.

Authors:  Ping Wu; Liang Li; Weijia Sun
Journal:  Biosci Rep       Date:  2018-11-15       Impact factor: 3.840

10.  Safety and efficacy of total parenteral nutrition versus total enteral nutrition for patients with severe acute pancreatitis: a meta-analysis.

Authors:  Wen Li; Jixi Liu; Shuqiao Zhao; Jingtao Li
Journal:  J Int Med Res       Date:  2018-07-01       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.